Enhanced neutrophil expression of annexin-1 in coronary artery disease

Metabolism: Clinical and Experimental

Volumn 59, Issue 3, 2010, Pages 433-440

  Särndahl, Eva ^a   Bergström, Ida ^b   Nijm, Johnny ^b   Forslund, Tony ^b   Perretti, Mauro ^c   Jonasson, Lena ^b  

^a ÖREBRO UNIVERSITY   (Sweden)

^b LINKÖPING UNIVERSITY   (Sweden)

^c QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CD18 ANTIGEN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FORMYLPEPTIDE RECEPTOR LIKE 1; GLUCOCORTICOID RECEPTOR; GLUCOCORTICOID RECEPTOR ALPHA; GLUCOCORTICOID RECEPTOR BETA; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROCORTISONE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LEUKOTRIENE B4; LIPOCORTIN 1; LOW DENSITY LIPOPROTEIN CHOLESTEROL; REACTIVE OXYGEN METABOLITE;

ADULT; ARTICLE; CIRCADIAN RHYTHM; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; FEMALE; FLOW CYTOMETRY; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; LOW DRUG DOSE; MALE; NEUTROPHIL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SALIVA ANALYSIS; SALIVA LEVEL;

AGED; ANGIOGRAPHY; ANNEXIN A1; ANTIGENS, CD18; CIRCADIAN RHYTHM; CORONARY ARTERY DISEASE; FEMALE; FLOW CYTOMETRY; GLUCOCORTICOIDS; HUMANS; HYDROCORTISONE; LEUKOTRIENE B4; MALE; MIDDLE AGED; NEUTROPHILS; PHENOTYPE; REACTIVE OXYGEN SPECIES; RECEPTORS, FORMYL PEPTIDE; RECEPTORS, GLUCOCORTICOID; RECEPTORS, LIPOXIN; SALIVA;

EID: 76249118653     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.metabol.2009.07.044     Document Type: Article

References (40)

1. Hansson G.K. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 352 (2005) 1685-1695
2. Weber C., Zernecke A., and Libby P. The multifaceted contributions of leukocyte subsets to atherosclerosis: lessons from mouse models. Nat Rev Immunol 8 (2008) 802-815
3. Jonasson L., Linderfalk C., Olsson J., Wikby A., and Olsson A.G. Systemic T-cell activation in stable angina pectoris. Am J Cardiol 89 (2002) 754-756
4. Nijm J., Wikby A., Tompa A., Olsson A.G., and Jonasson L. Circulating levels of proinflammatory cytokines and neutrophil-platelet aggregates in patients with coronary artery disease. Am J Cardiol 95 (2005) 452-456
5. Sarndahl E., Bergstrom I., Brodin V.P., Nijm J., Setterud H.L., and Jonasson L. Neutrophil activation status in stable coronary artery disease. PLoS ONE 2 (2007) e1056
6. Paulsson J., Dadfar E., Held C., Jacobson S.H., and Lundahl J. Activation of peripheral and in vivo transmigrated neutrophils in patients with stable coronary artery disease. Atherosclerosis 192 (2007) 328-334
7. Hansson G.K., and Libby P. The immune response in atherosclerosis: a double-edged sword. Nat Rev Immunol 6 (2006) 508-519
8. Mallat Z., Ait-Oufella H., and Tedgui A. Regulatory T-cell immunity in atherosclerosis. Trends Cardiovasc Med 17 (2007) 113-118
9. Yudoh K., Matsuno H., Nakazawa F., Yonezawa T., and Kimura T. Reduced expression of the regulatory CD4+ T cell subset is related to Th1/Th2 balance and disease severity in rheumatoid arthritis. Arthritis Rheum 43 (2000) 617-627
10. Roman M.J., Shanker B.A., Davis A., et al. Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus. N Engl J Med 349 (2003) 2399-2406
11. Sternberg E.M. Neuroendocrine regulation of autoimmune/inflammatory disease. J Endocrinol 169 (2001) 429-435
12. Calcagni E., and Elenkov I. Stress system activity, innate and T helper cytokines, and susceptibility to immune-related diseases. Ann N Y Acad Sci 1069 (2006) 62-76
13. Nijm J., Kristenson M., Olsson A.G., and Jonasson L. Impaired cortisol response to acute stressors in patients with coronary disease. Implications for inflammatory activity. J Intern Med 262 (2007) 375-384
14. DeRijk R., and Sternberg E.M. Corticosteroid resistance and disease. Ann Med 29 (1997) 79-82
15. Chikanza I.C. Mechanisms of corticosteroid resistance in rheumatoid arthritis: a putative role for the corticosteroid receptor beta isoform. Ann N Y Acad Sci 966 (2002) 39-48
16. Lewis-Tuffin L.J., and Cidlowski J.A. The physiology of human glucocorticoid receptor beta (hGRbeta) and glucocorticoid resistance. Ann N Y Acad Sci 1069 (2006) 1-9
17. Hannon R., Croxtall J.D., Getting S.J., et al. Aberrant inflammation and resistance to glucocorticoids in annexin 1-/- mouse. FASEB J 17 (2003) 253-255
18. Perretti M., and Flower R.J. Modulation of IL-1-induced neutrophil migration by dexamethasone and lipocortin 1. J Immunol 150 (1993) 992-999
19. Yang Y., Hutchinson P., and Morand E.F. Inhibitory effect of annexin I on synovial inflammation in rat adjuvant arthritis. Arthritis Rheum 42 (1999) 1538-1544
20. Damazo A.S., Yona S., D'Acquisto F., Flower R.J., Oliani S.M., and Perretti M. Critical protective role for annexin 1 gene expression in the endotoxemic murine microcirculation. Am J Pathol 166 (2005) 1607-1617
21. Mulla A., Leroux C., Solito E., and Buckingham J.C. Correlation between the antiinflammatory protein annexin 1 (lipocortin 1) and serum cortisol in subjects with normal and dysregulated adrenal function. J Clin Endocrinol Metab 90 (2005) 557-562
22. Francis J.W., Balazovich K.J., Smolen J.E., Margolis D.I., and Boxer L.A. Human neutrophil annexin I promotes granule aggregation and modulates Ca(2+)-dependent membrane fusion. J Clin Invest 90 (1992) 537-544
23. Perretti M., and Flower R.J. Measurement of lipocortin 1 levels in murine peripheral blood leukocytes by flow cytometry: modulation by glucocorticoids and inflammation. Br J Pharmacol 118 (1996) 605-610
24. Perretti M., Chiang N., La M., et al. Endogenous lipid- and peptide-derived anti-inflammatory pathways generated with glucocorticoid and aspirin treatment activate the lipoxin A4 receptor. Nat Med 8 (2002) 1296-1302
25. Hayhoe R.P., Kamal A.M., Solito E., Flower R.J., Cooper D., and Perretti M. Annexin 1 and its bioactive peptide inhibit neutrophil-endothelium interactions under flow: indication of distinct receptor involvement. Blood 107 (2006) 2123-2130
26. Aardal E., and Holm A.C. Cortisol in saliva-reference ranges and relation to cortisol in serum. Eur J Clin Chem Clin Biochem 33 (1995) 927-932
27. Patcha V., Wigren J., Winberg M.E., Rasmusson B., Li J., and Sarndahl E. Differential inside-out activation of beta2-integrins by leukotriene B4 and fMLP in human neutrophils. Exp Cell Res 300 (2004) 308-319
28. Forsberg M., Druid P., Zheng L., Stendahl O., and Sarndahl E. Activation of Rac2 and Cdc42 on Fc and complement receptor ligation in human neutrophils. J Leukoc Biol 74 (2003) 611-619
29. Fantidis P., Perez De Prada T., Fernandez-Ortiz A., et al. Morning cortisol production in coronary heart disease patients. Eur J Clin Invest 32 (2002) 304-308
30. Koertge J., Al-Khalili F., Ahnve S., Janszky I., Svane B., and Schenck-Gustafsson K. Cortisol and vital exhaustion in relation to significant coronary artery stenosis in middle-aged women with acute coronary syndrome. Psychoneuroendocrinology 27 (2002) 893-906
31. Matthews K., Schwartz J., Cohen S., and Seeman T. Diurnal cortisol decline is related to coronary calcification: CARDIA study. Psychosom Med 68 (2006) 657-661
32. Harbuz M.S., Chover-Gonzalez A.J., and Jessop D.S. Hypothalamo-pituitary-adrenal axis and chronic immune activation. Ann N Y Acad Sci 992 (2003) 99-106
33. Perretti M., and Flower R.J. Annexin 1 and the biology of the neutrophil. J Leukoc Biol 76 (2004) 25-29
34. Kuipers H.F., and van den Elsen P.J. Immunomodulation by statins: inhibition of cholesterol vs. isoprenoid biosynthesis. Biomed Pharmacother 61 (2007) 400-407
35. Bohm M., Herrmann W., Wassmann S., Laufs U., and Nickenig G. Does statin therapy influence steroid hormone synthesis?. Z Kardiol 93 (2004) 43-48
36. Nugent A.M., Neely D., Young I., et al. Stress responses after treatment of hypercholesterolaemia with simvastatin. Br J Clin Pharmacol 36 (1993) 474-477
37. Travia D., Tosi F., Negri C., Faccini G., Moghetti P., and Muggeo M. Sustained therapy with 3-hydroxy-3-methylglutaryl-coenzyme-A reductase inhibitors does not impair steroidogenesis by adrenals and gonads. J Clin Endocrinol Metab 80 (1995) 836-840
38. Armando I., Volpi S., Aguilera G., and Saavedra J.M. Angiotensin II AT1 receptor blockade prevents the hypothalamic corticotropin-releasing factor response to isolation stress. Brain Res 1142 (2007) 92-99
39. Ott I., Neumann F.J., Gawaz M., Schmitt M., and Schomig A. Increased neutrophil-platelet adhesion in patients with unstable angina. Circulation 94 (1996) 1239-1246
40. Lindmark E., Wallentin L., and Siegbahn A. Blood cell activation, coagulation, and inflammation in men and women with coronary artery disease. Thromb Res 103 (2001) 249-259